KNOX5 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
KNOX5Homeobox protein knotted-1-like 5 antibody; Fragment antibody
Target Names
KNOX5
Uniprot No.

Target Background

Function
This antibody likely binds to the DNA sequence 5'-TGAC-3'.
Protein Families
TALE/KNOX homeobox family
Subcellular Location
Nucleus.
Tissue Specificity
Strongly expressed in ear inflorescence primordia and shoot meristem. Weakly expressed in embryos. Absent from leaves.

Q&A

What is KNOX5 and why is it significant in plant research?

KNOX5 (Knotted1-like homeobox 5) belongs to the class I KNOX gene family, which encodes homeodomain-containing transcription factors crucial for plant development, particularly in meristem maintenance and organ boundary establishment. The KNOX5 protein, identified in maize (Zea mays) with UniProt accession P56663, functions as part of an evolutionarily conserved family of developmental regulators .

The significance of KNOX5 in plant research stems from its role in controlling plant architecture through regulation of meristematic regions and organ development. Understanding KNOX5 function contributes to our knowledge of fundamental developmental processes and potentially offers insights that could be applied to crop improvement strategies. Research on KNOX homeobox genes like KNOX5 has revealed their importance in maintaining the undifferentiated state of cells in the shoot apical meristem while preventing premature differentiation.

How does KNOX5 relate to other members of the KNOX homeobox gene family?

KNOX5 is one of several KNOX genes identified in plants, with others including KNOX1 (P56659), KNOX2 (P56660), KNOX8 (P56666), and KNOX11 (P56668) as evidenced in the UniProt database . The KNOX gene family is divided into two primary classes based on phylogenetic relationships, expression patterns, and functional characteristics:

KNOX GeneUniProt IDSpeciesClassPrimary Function
KNOX1/KN-1P56659/P24345Zea maysIMeristem maintenance
KNOX2P56660Zea maysIDevelopmental regulation
KNOX5P56663Zea maysIMeristem regulation
KNOX8P56666Zea maysIIDifferentiation processes
KNOX11P56668Zea maysIISecondary development

KNOX5 shares structural features with other KNOX proteins, including the KNOX domain (a conserved region outside the homeodomain) and the homeodomain itself, which facilitates DNA binding. These structural similarities reflect their common evolutionary origin and related functions in developmental regulation. Class I KNOX genes, including KNOX5, are typically expressed in meristematic regions and excluded from determinate organs, while Class II genes often show broader expression patterns.

What are the evolutionary implications of KNOX5 in plant development?

The evolutionary significance of KNOX5 must be considered within the broader context of KNOX gene evolution across plant lineages. KNOX genes represent an ancient family that predates the divergence of major plant groups, with homologs found across vascular plants. The presence of "knots in the family tree" of KNOX genes refers to the complex evolutionary relationships that have shaped this gene family through time .

From an evolutionary perspective, KNOX genes have undergone multiple duplication and diversification events, leading to subfunctionalization and neofunctionalization. This process has contributed to morphological innovation throughout plant evolution. The KNOX family expansion correlates with increasing complexity in plant form, suggesting their role in the evolution of novel developmental patterns.

Comparative studies between species indicate that KNOX genes have been pivotal in the evolution of leaf morphology, particularly in the transition from simple to complex leaf forms. The precise evolutionary position of KNOX5 within this framework represents an active area of research, with implications for understanding both plant development and evolutionary biology.

What are the primary research applications for KNOX5 Antibody in plant biology?

KNOX5 Antibody serves multiple research applications in plant biology, primarily centered on detecting and characterizing KNOX5 protein expression patterns. The main applications include:

  • Protein Expression Analysis: Western blotting to quantify KNOX5 protein levels in different tissues, developmental stages, or under various environmental conditions.

  • Immunolocalization Studies: Immunohistochemistry (IHC) and immunofluorescence techniques to visualize the spatial distribution of KNOX5 within plant tissues, particularly focusing on meristematic regions and developing organs.

  • Chromatin Immunoprecipitation (ChIP): Identifying DNA regions bound by KNOX5 transcription factor, thereby elucidating its target genes and regulatory networks.

  • Protein-Protein Interaction Studies: Co-immunoprecipitation experiments to identify interaction partners of KNOX5, providing insights into the protein complexes involved in developmental regulation.

  • Developmental Biology Research: Tracking KNOX5 expression during critical developmental transitions to understand its role in meristem maintenance and organogenesis.

These applications collectively contribute to our understanding of how KNOX5 functions within the plant developmental framework, particularly in model systems like maize where specialized antibodies are available .

How can KNOX5 Antibody be used in immunohistochemistry experiments?

Immunohistochemistry (IHC) with KNOX5 Antibody requires careful methodology to achieve specific labeling in plant tissues. The following protocol outlines the key steps and considerations:

Sample Preparation:

  • Harvest plant tissue at the appropriate developmental stage

  • Fix tissue in 4% paraformaldehyde in PBS (pH 7.4) for 12-24 hours at 4°C

  • Dehydrate through an ethanol series (30%, 50%, 70%, 85%, 95%, 100%)

  • Clear with xylene and embed in paraffin

  • Section tissues at 5-10 μm thickness using a microtome

Immunohistochemistry Protocol:

  • Deparaffinize sections with xylene and rehydrate through descending ethanol series

  • Perform antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0) at 95°C for 20 minutes

  • Block endogenous peroxidase activity with 3% H₂O₂ in methanol

  • Block non-specific binding with 3-5% normal serum in PBS with 0.1% Triton X-100

  • Apply primary KNOX5 Antibody (CSB-PA348724XA01ZAX) at optimized dilution (typically 1:100 to 1:500) and incubate overnight at 4°C

  • Wash extensively with PBS (3-5 times, 5 minutes each)

  • Apply appropriate biotinylated secondary antibody and incubate for 1-2 hours at room temperature

  • Wash with PBS

  • Apply avidin-biotin complex and develop with DAB substrate

  • Counterstain with hematoxylin, dehydrate, and mount

Methodological Considerations:

  • Always include positive and negative controls (including secondary-only controls)

  • Validate antibody specificity using tissues with known KNOX5 expression patterns

  • Consider using fluorescent detection methods for co-localization studies

  • For maize tissues, which can be challenging for IHC, extended fixation and antigen retrieval optimization may be necessary

  • Document specific parameters used (antibody dilutions, incubation times) to ensure reproducibility

What are the optimal protocols for Western blot analysis using KNOX5 Antibody?

Western blot analysis with KNOX5 Antibody requires optimization for plant tissue samples, which present unique challenges due to high levels of interfering compounds. Here is a detailed protocol with critical parameters:

Protein Extraction:

  • Grind plant tissue in liquid nitrogen to a fine powder

  • Extract proteins using buffer containing:

    • 50 mM Tris-HCl (pH 8.0)

    • 150 mM NaCl

    • 1% Triton X-100

    • 0.5% sodium deoxycholate

    • 2 mM EDTA

    • 1 mM PMSF

    • Protease inhibitor cocktail

  • Add 5% polyvinylpolypyrrolidone (PVPP) to remove phenolic compounds

  • Centrifuge at 12,000g for 15 minutes at 4°C

  • Collect supernatant and determine protein concentration

Western Blot Procedure:

  • Prepare samples by mixing protein extract with Laemmli buffer and heat at 95°C for 5 minutes

  • Load 20-50 μg of protein per lane on SDS-PAGE (10-12% acrylamide)

  • Separate proteins at 100V until dye front reaches bottom of gel

  • Transfer to PVDF membrane (0.45 μm pore size) at 100V for 1 hour at 4°C

  • Block membrane with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Incubate with KNOX5 Antibody (CSB-PA348724XA01ZAX) at 1:1000 dilution in TBST with 1% BSA overnight at 4°C

  • Wash 3-5 times with TBST, 5 minutes each

  • Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature

  • Wash 3-5 times with TBST

  • Develop using ECL substrate and image

Critical Parameters for KNOX5 Detection:

  • Expected molecular weight of KNOX5 protein: ~42-45 kDa

  • Sufficient heating of samples is essential to ensure complete denaturation

  • Longer blocking times (2-3 hours) may be necessary to reduce background

  • Pre-adsorption of primary antibody with non-specific proteins can improve specificity

  • Quantification should include normalization to appropriate loading controls (e.g., actin, tubulin)

Optimization Table for Troubleshooting:

IssuePotential CauseSolution
No signalInsufficient proteinIncrease loading amount or concentrate sample
Inefficient transferOptimize transfer conditions, verify with Ponceau S
Multiple bandsNon-specific bindingIncrease blocking time, optimize antibody dilution
Protein degradationAdd additional protease inhibitors during extraction
High backgroundInsufficient washingIncrease number and duration of washes
Excessive antibodyDilute primary and secondary antibodies further

What is the specificity of KNOX5 Antibody across different plant species?

The specificity of KNOX5 Antibody (CSB-PA348724XA01ZAX) has been primarily established for Zea mays (maize) , but its cross-reactivity with KNOX5 homologs in other plant species is an important consideration for comparative studies. Cross-species reactivity depends on the conservation of epitopes recognized by the antibody and must be empirically determined for each species of interest.

The following table summarizes predicted cross-reactivity based on protein sequence homology analysis:

Plant SpeciesKNOX5 HomologSequence Identity to Maize KNOX5Predicted Cross-reactivity
Zea maysKNOX5 (P56663)100%High
Oryza sativaOSH15/OSH43~75-80%Moderate
Arabidopsis thalianaKNAT1/BP~65-70%Low-Moderate
Triticum aestivumTaKnox5~80-85%Moderate-High
Hordeum vulgareHvKnox5~75-80%Moderate
Solanum lycopersicumTKn2/LeT6~60-65%Low

Methodological Considerations for Cross-species Applications:

  • Validation Requirement: Western blot analysis with positive and negative controls from the target species

  • Epitope Mapping: If possible, determine the epitope recognized by the antibody to predict cross-reactivity

  • Pre-adsorption Controls: Perform pre-adsorption with recombinant proteins from the target species

  • Dilution Optimization: Cross-reactive applications may require different antibody dilutions

  • Signal Verification: Confirm signals using alternative methods (e.g., RNA expression, GFP fusion proteins)

How should researchers validate KNOX5 Antibody specificity in their experimental system?

Validation of KNOX5 Antibody specificity is a critical step to ensure reliable and reproducible results. A comprehensive validation approach includes multiple complementary methods:

Essential Validation Methods:

  • Western Blot Analysis with Appropriate Controls

    • Wild-type samples with known KNOX5 expression

    • knox5 mutant or knockdown samples (genetic negative control)

    • Recombinant KNOX5 protein (positive control)

    • Related KNOX family proteins to assess cross-reactivity

  • Immunoprecipitation Followed by Mass Spectrometry

    • Confirm that KNOX5 is the predominant protein pulled down

    • Identify any cross-reactive proteins

  • Immunohistochemistry Validation

    • Compare localization patterns with in situ hybridization results

    • Test antibody on tissues with known expression patterns

    • Include appropriate negative controls (pre-immune serum, secondary-only)

  • Peptide Competition Assay

    • Pre-incubate antibody with immunizing peptide

    • Loss of signal confirms specificity for the target epitope

Advanced Validation Methods:

  • CRISPR/Cas9 Knockout Validation

    • Generate CRISPR/Cas9 knockout of KNOX5

    • Loss of specific band/signal confirms antibody specificity

  • Heterologous Expression System

    • Express tagged KNOX5 in a heterologous system

    • Confirm co-localization of tag and antibody signals

Validation Scoring System:
A systematic approach to antibody validation can be implemented using a scoring system:

Validation MethodOutcomeScore
Western BlotSingle band at expected MW+2
Multiple bands including expected MW+1
No band at expected MW-2
Genetic ControlsSignal absent in knockout/knockdown+3
Signal reduced in heterozygous samples+2
No difference in signal-3
Peptide CompetitionComplete signal elimination+3
Partial signal reduction+2
No effect on signal-2
IP-MSKNOX5 identified as major component+3
KNOX5 present with other proteins+1
Expression CorrelationAntibody signal correlates with mRNA+2
Poor correlation with mRNA-1

A cumulative score ≥7 indicates a well-validated antibody suitable for research applications.

What are the recommended methods for optimizing KNOX5 Antibody signal-to-noise ratio?

Optimizing signal-to-noise ratio is crucial for obtaining clean, interpretable results with KNOX5 Antibody. The following methodological approaches address common challenges in plant tissue analysis:

Extraction and Sample Preparation Optimization:

  • Buffer Optimization for Plant Tissues

    • Include reducing agents (e.g., DTT, 2-mercaptoethanol) to maintain protein integrity

    • Add 2-5% PVPP to remove phenolic compounds that can interfere with antibody binding

    • Include plant-specific protease inhibitor cocktails to prevent degradation

  • Subcellular Fractionation

    • Enrich for nuclear fraction where KNOX5 transcription factor is predominantly located

    • Reduces cytoplasmic background signals and concentrates target protein

Immunoassay Parameter Optimization:

  • Antibody Titration Matrix
    The following titration matrix can guide optimization efforts:

    Primary Antibody DilutionSecondary Antibody Dilution
    1:1001:1000, 1:2000, 1:5000
    1:5001:1000, 1:2000, 1:5000
    1:10001:1000, 1:2000, 1:5000
    1:20001:1000, 1:2000, 1:5000
  • Blocking Optimization

    • Test different blocking agents: 5% milk, 5% BSA, commercial blockers

    • Optimize blocking time (1-16 hours) and temperature

    • For plant tissues, adding 0.1-0.3% Tween-20 to blocking solution can reduce non-specific binding

  • Washing Protocol Enhancement

    • Increase number of washes (5-7 washes instead of standard 3)

    • Extend washing time (10-15 minutes per wash)

    • Use higher salt concentration in wash buffer (up to 500 mM NaCl) to reduce non-specific ionic interactions

Advanced Signal Enhancement Techniques:

  • Signal Amplification Methods

    • Tyramide signal amplification for immunohistochemistry

    • Biotin-streptavidin amplification systems

    • Polymeric detection systems (e.g., EnVision, PowerVision)

  • Background Reduction Strategies

    • Pre-adsorption of primary antibody with plant tissue extract lacking KNOX5

    • Pre-clearing lysates with Protein A/G beads before immunoprecipitation

    • Use of monovalent Fab fragments to block endogenous immunoglobulins

What are common sources of variability in KNOX5 Antibody experimental results?

Variability in KNOX5 Antibody experimental results can arise from multiple sources, complicating data interpretation and reproducibility. Understanding these sources enables researchers to implement appropriate controls and standardization measures:

Biological Sources of Variability:

  • Developmental Stage Variation

    • KNOX5 expression is highly regulated during plant development

    • Precise staging of samples is critical for meaningful comparisons

    • Implement standardized staging criteria and document thoroughly

  • Tissue-Specific Expression Patterns

    • KNOX5 shows distinct expression patterns across different plant tissues

    • Careful dissection and anatomical verification is essential

    • Document tissue collection protocols with anatomical landmarks

  • Environmental Influences

    • Growth conditions affect KNOX gene expression

    • Control and document temperature, light, humidity, and nutrient conditions

    • Consider circadian patterns in expression

Technical Sources of Variability:

  • Antibody Lot-to-Lot Variation

    • Different production lots may have varying specificity and sensitivity

    • Record lot numbers and validate each new lot against previous standards

    • Consider creating a reference standard for internal calibration

  • Sample Processing Effects

    • Fixation parameters significantly impact epitope preservation

    • Protein extraction efficiency varies with tissue type

    • Standardize and validate extraction protocols for each tissue type

  • Detection System Variability

    • ECL reagent age affects Western blot sensitivity

    • Incubation temperature fluctuations alter reaction kinetics

    • Implement standard curves and positive controls with each experiment

Variability SourceEstimated ContributionControl MethodValidation Metric
Biological variation30-40%Pooled samples, increased replicationCoefficient of variation
Developmental timing20-25%Strict staging criteriaMorphological markers
Antibody lot variation15-20%Single lot for entire studyStandard sample comparison
Extraction efficiency10-15%Standardized protocol, internal standardsRecovery of spiked protein
Detection sensitivity10-15%Calibration curves, exposure time standardizationSignal linearity assessment

How should contradictory results with KNOX5 Antibody be interpreted and resolved?

Contradictory results when using KNOX5 Antibody may arise from various sources and require systematic investigation to resolve. This methodological approach provides a framework for addressing such discrepancies:

Step 1: Categorize the Type of Contradiction
First, identify the specific nature of the contradiction:

  • Method-dependent contradictions: Different results between techniques (e.g., Western blot vs. immunohistochemistry)

  • Sample-dependent contradictions: Inconsistent results across biological samples

  • Antibody-dependent contradictions: Results that contradict known biology or previous findings

  • Laboratory-dependent contradictions: Inability to reproduce published results

Step 2: Systematic Investigation Process

Technical Validation:

  • Verify antibody specificity through:

    • Western blot analysis for correct molecular weight (~42-45 kDa for KNOX5)

    • Peptide competition assays

    • Testing on knockout/knockdown samples

  • Examine technical parameters:

    • Sample preparation methods (fixation, extraction buffers)

    • Incubation conditions (time, temperature, antibody concentration)

    • Detection systems (substrate, exposure time)

Biological Validation:

  • Verify gene expression using orthogonal methods:

    • RT-qPCR for KNOX5 mRNA expression

    • In situ hybridization for spatial expression patterns

    • Reporter gene constructs (e.g., KNOX5 promoter:GUS)

  • Consider biological context:

    • Developmental stage specificity

    • Tissue-specific regulation

    • Environmental influences on expression

Decision Matrix for Resolving Contradictions:

Type of ContradictionInvestigation ApproachResolution Strategy
Method-dependentMethodological optimizationDetermine which method is more appropriate for specific question
Sample-dependentIncrease biological replicatesStatistical analysis to identify outliers and patterns
Antibody-dependentEpitope mapping, antibody validationConsider alternative antibodies or complementary approaches
Laboratory-dependentCollaborative cross-validationStandardize protocols through detailed methods exchange

How does KNOX5 Antibody performance compare to other methods for studying KNOX5 expression?

Comparing KNOX5 Antibody-based methods with alternative approaches provides critical context for experimental design decisions. Each method offers distinct advantages and limitations for studying KNOX5 expression:

Comprehensive Method Comparison:

MethodPrincipleResolution LevelAdvantagesLimitationsComplementarity with Antibody Methods
KNOX5 Antibody (Western blot)Protein detection via epitope bindingTissue/organ levelQuantifies protein levels, Detects post-translational modificationsLimited spatial resolution, Requires protein extraction-
KNOX5 Antibody (IHC/IF)In situ protein localizationCellular/subcellularProvides spatial context, Can detect protein localizationFixation artifacts, Background issues in plant tissues-
RT-qPCRmRNA quantificationTissue/organ levelHigh sensitivity, Quantitative, Relatively simpleNo spatial information, Measures mRNA not proteinValidates transcript-protein correlation
RNA in situ hybridizationmRNA localizationCellularSpatial expression pattern, mRNA detectionTechnical complexity, No protein informationConfirms spatial expression patterns
KNOX5 promoter:reporterTranscriptional activityCellular/tissueVisualizes promoter activity in vivo, Compatible with live imagingMay miss distal regulatory elements, No protein informationValidates expression domains
ChIP-seq (using KNOX5 Antibody)DNA binding site identificationGenome-wideMaps target genes, Reveals regulatory networksComplex analysis, Requires high-quality antibodyExtends functional understanding
CRISPR/Cas9 knockout phenotypingLoss-of-function analysisOrganism levelReveals function through phenotype, Genetic specificityNot directly measuring expression, Potential compensationValidates antibody specificity

Quantitative Performance Metrics:
The following table presents quantitative assessments of different methods for KNOX5 analysis:

MethodDetection LimitDynamic RangeSpatial ResolutionTemporal ResolutionRelative CostTechnical Complexity
Western blot~10 ng protein10-100 foldTissue levelHours-days++++
IHC/IF~100 protein molecules/cell5-50 foldSubcellularFixed timepoint+++++
RT-qPCR~10 copies mRNA>1000 foldTissue levelMinutes-hours++
RNA in situ~25-50 copies mRNA/cell10-50 foldCellularFixed timepoint+++++++
Promoter:reporterVariable10-100 foldCellularMinutes-hours (live)++++ (creation) + (use)+++ (creation) + (use)
ChIP-seq~1000 cells10-100 foldGenomic regionsHours++++++++
CRISPR/Cas9N/AN/AOrganismalDevelopmental++++++++

What are the advantages and limitations of using KNOX5 Antibody versus genetic approaches?

Understanding the relative strengths and limitations of antibody-based versus genetic approaches is crucial for designing effective research strategies for KNOX5 characterization:

Fundamental Approach Comparison:

AspectKNOX5 Antibody ApproachGenetic Approach
Basic principleDetection of endogenous protein via epitope recognitionModification of gene expression or structure
Level of analysisProtein (final gene product)DNA or RNA (genetic material or intermediate)
Temporal aspectDetects existing proteinCan track through development with reporter systems
Key techniquesWestern blot, IHC, IP, ChIPCRISPR/Cas9, RNAi, overexpression, reporter fusions

Detailed Comparative Analysis:

  • Detection of Native Protein Expression

    • Antibody Advantage: Directly measures endogenous protein levels and localization without genetic modification

    • Genetic Limitation: Reporter fusions may alter protein behavior or expression patterns

    • Research Impact: Antibody approaches provide more accurate representation of natural expression patterns

  • Post-translational Modifications

    • Antibody Advantage: Can detect specific post-translational modifications with modification-specific antibodies

    • Genetic Limitation: Genetic reporters typically cannot distinguish protein modifications

    • Research Impact: Critical for understanding KNOX5 regulation, as plant transcription factors are extensively regulated post-translationally

  • Temporal Resolution

    • Antibody Limitation: Typically requires sample fixation, limiting temporal resolution

    • Genetic Advantage: Live imaging with fluorescent protein fusions allows continuous monitoring

    • Research Impact: Genetic approaches better for dynamic developmental processes

  • Spatial Resolution

    • Antibody Advantage: Subcellular localization without protein fusion that might affect localization

    • Genetic Advantage: Live-cell imaging can track movement between subcellular compartments

    • Research Application: Combine approaches for validation of localization patterns

  • Technical Considerations

    • Antibody Limitation: Potential cross-reactivity, especially within KNOX family

    • Genetic Limitation: Potential off-target effects with CRISPR/Cas9 or RNAi

    • Research Strategy: Validate findings across both approaches

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.